Zhan Chao Liang
Chief Investment Officer at Shanghai Med-Fine Asset Management Co. Ltd.
Profile
Zhan Chao Liang is currently the Director at Beijing Mabworks Biotech Co., Ltd.
and the Chief Investment Officer & Partner at Shanghai Med-Fine Asset Management Co. Ltd.
He completed his undergraduate degree from Hlj August First Land Reclamation University in 2008 and his graduate degree from the Academy of Military Medical Sciences in 2011.
Zhan Chao Liang active positions
| Companies | Position | Start |
|---|---|---|
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Director/Board Member | 01/05/2016 |
| Shanghai Med-Fine Asset Management Co. Ltd. | Chief Investment Officer | 01/04/2015 |
Training of Zhan Chao Liang
| Hlj August First Land Reclamation University | Undergraduate Degree |
| Academy of Military Medical Sciences | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
| Shanghai Med-Fine Asset Management Co. Ltd. |
- Stock Market
- Insiders
- Zhan Chao Liang
